IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

Indian Pharma Network (IPN)

Medicines For Rectum Cancer Treatment

IPN, New Delhi can facilitate Rectum cancer patient to “import of  Medicines For Rectum Cancer Treatment” for personal use under “patient name basis” treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

Rectum Cancer Treatment

The treatment of rectal cancer can vary depending on the stage and other characteristics of the cancer. Here are some of the medications that may be used to treat rectal cancer:

Get Access FDA Approved Medicines For Rectum Cancer Treatment

Chemotherapy is a common treatment for rectal cancer, which is a type of cancer that starts in the rectum. The following are some chemotherapy medications that may be used to treat rectal cancer:

  • 5-fluorouracil (5-FU):
    This is a chemotherapy drug that has been used for many years to treat rectal cancer. It is usually given by injection into a vein or taken orally as a pill.
  • Capecitabine (Xeloda):
    This is an oral chemotherapy drug that is similar to 5-FU. It is often used in combination with other chemotherapy drugs for the treatment of rectal cancer.
  • Oxaliplatin (Eloxatin):
    This is a chemotherapy drug that is often used in combination with 5-FU or capecitabine for the treatment of advanced rectal cancer.
  • Irinotecan (Camptosar):
    This is a chemotherapy drug that is often used in combination with 5-FU or capecitabine for the treatment of advanced rectal cancer.
  • Fluorouracil and Leucovorin (5-FU/LV):
    This combination of medications is often used for the treatment of rectal cancer.

It’s important to note that the choice of chemotherapy drugs used to treat rectal cancer depends on various factors, including the stage and location of the cancer, as well as the overall health of the patient. Your healthcare provider will determine the most appropriate treatment plan for you.

Targeted therapy is a type of cancer treatment that uses drugs to target specific molecules or pathways that are involved in the growth and spread of cancer cells. The following are some targeted therapy medications that may be used to treat rectal cancer:

  • Bevacizumab (Avastin):
    This medication is a vascular endothelial growth factor (VEGF) inhibitor that works by blocking the growth of blood vessels that feed tumors. It is sometimes used in combination with chemotherapy for the treatment of advanced rectal cancer.
  • Cetuximab (Erbitux):
    This medication is an epidermal growth factor receptor (EGFR) inhibitor that is sometimes used in combination with chemotherapy for the treatment of advanced rectal cancer.
  • Panitumumab (Vectibix):
    This medication is also an EGFR inhibitor that works in a similar way to cetuximab. It is sometimes used in combination with chemotherapy for the treatment of advanced rectal cancer.

It’s important to note that the use of targeted therapy medications for rectal cancer is generally limited to patients with specific genetic mutations or biomarkers. Your healthcare provider will determine the most appropriate treatment plan for you based on your individual case.

Immunotherapy is a type of cancer treatment that works by stimulating the immune system to recognize and attack cancer cells. The following are some immunotherapy medications that may be used to treat rectal cancer:

  • Pembrolizumab (Keytruda):
    This medication is a programmed cell death protein 1 (PD-1) inhibitor that works by blocking the interaction between PD-1 and its ligands, which can suppress the immune system. It is sometimes used to treat advanced rectal cancer that has certain genetic mutations.
  • Nivolumab (Opdivo):
    This medication is also a PD-1 inhibitor that works in a similar way to pembrolizumab. It is sometimes used to treat advanced rectal cancer that has certain genetic mutations.
  • Ipilimumab (Yervoy):
    This medication is a cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibitor that works by blocking the interaction between CTLA-4 and its ligands, which can also suppress the immune system. It is sometimes used in combination with nivolumab to treat advanced rectal cancer that has certain genetic mutations.

It’s important to note that the use of immunotherapy medications for rectal cancer is generally limited to patients with specific genetic mutations or biomarkers. Your healthcare provider will determine the most appropriate treatment plan for you based on your individual case.

Radiation therapy uses high-energy radiation to kill cancer cells. It is typically used in combination with chemotherapy for locally advanced rectal cancer.

It’s important to note that treatment plans for rectal cancer are highly individualized, and the medications and treatments used will depend on the specific characteristics of the cancer and the individual patient’s needs. It’s best to consult with a healthcare provider to determine the most appropriate treatment plan for your specific case.

Legitimate Healthcare Consultant and Facilitator In Delhi

If you have a question relating to anti-cancer medicines approved for treatment of Rectum Cancer, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in  as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Legitimate Healthcare Consultant and Facilitator

If you have a question relating to anti-cancer medicines approved for treatment of Pancreatic Cancer, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in  as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Query Form For Medications

Disclaimer

Please note that this article serves purely informational purposes, and Indian Pharma Network (“IPN, Delhi”) bears no responsibility for the opinions, advice, or information conveyed by the author, reviewer, or originator. It is important to note that this article should not be considered a substitute for medical advice, diagnosis, or treatment. Always seek guidance from your trusted physician or qualified healthcare professional to assess your medical situation. A qualified doctor has reviewed the aforementioned article, and IPN, Delhi disclaims any liability for any information or services rendered by third parties.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398